Revenue → Total operating costs: $91.9BPremiums → Revenue: $78.0BTotal operating costs → Medical costs: $65.7BTotal operating costs → Operating costs: $14.1BProducts → Revenue: $11.9BTotal operating costs → Costs of products sold: $11.1BServices → Revenue: $8.9BRevenue → Operating income: $7.9BOperating income → Loss on sale of subsidiary: $7.1BPre tax income → Income after Tax (loss): $1.2BInvestment & other → Revenue: $1.0BTotal operating costs → Depreciation & amortization: $1.0BOperating income → Interest: $0.8BOperating income → Pre tax income: $0.0BPremiums: $78.0BRevenue: $99.8BProducts: $11.9BServices: $8.9BInvestment & other: $1.0BOperating income: $7.9BPre tax income: $1.2BIncome after Tax (loss): $1.2BInterest: $0.8BLoss on sale of subsidiary: $7.1BTotal operating costs: $91.9BMedical costs: $65.7BOperating costs: $14.1BCosts of products sold: $11.1BDepreciation & amortization: $1.0Bcreated with SankeyArt.comPremiums$78.0B7% Y/YRevenue$99.8B9% Y/YProducts$11.9B16% Y/YServices$8.9B10% Y/YInvestment & other$1.0B27% Y/YOperating income$7.9B-2% Y/YPre tax income$1.2B-22% Y/YIncome after Tax (loss)$1.2B-22% Y/YInterest$0.8B12% Y/YLoss on sale of subsidiary$7.1BTotal operating costs$91.9B9% Y/YMedical costs$65.7B10% Y/YOperating costs$14.1B0% Y/YCosts of products sold$11.1B18% Y/YDepreciation & amortization$1.0B3% Y/YUnitedHealth Group Q1 FY24 Income Statement
2022
Q4
2023
Q1 Q2 Q3 Full Year
2024
Q1 Q2